CME dividend analysis

CME dividend deep dive

CME returns 2.40% per year through the dividend at the current $34.00 share price. The payout sits at 54% of trailing earnings, leaving 46% as retained capital — the standard line for evaluating dividend safety alongside the company's free-cash-flow trajectory.

Pillar mix backing the CME dividend: Quality 59/100, Risk 36/100, and a payout-strain adjustment that lands the dividend safety at 57/100. The Risk pillar is the place to look first if leverage or earnings cyclicality is a concern.

Reinvested-distribution math on CME at $34.00: holding yield (2.40%) and growth (7.4%) constant, the cumulative income compounds to roughly 13.6% over 5 years, 29.0% over 10, 66.4% over 20.

On the peer line for CME: KO (5.00%), PG (1.50%), PEP (2.90%). The cohort-mean yield (3.13%) sets the baseline; the 2.40% read on CME is 0.73 pp below that anchor.

For CME cash-flow planning: ex-date 2026-03-01, settlement 2026-03-15, quarterly run-rate $0.205/share. Annualized: $0.82.

CME synthesis: yield 2.40%, growth 7.4%, safety 57/100, payout 54%. The next earnings line will tell whether free-cash-flow conversion supports the current trajectory.